Viewing nowExosium Tablet 40 mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Korea Pharmaceutical Co., Ltd.

MFDS item code 202007780 · Approved 2020.11.12 · Insurance code 642803300
Treatment of reflux, Zollinger-Ellison syndrome, and ulcers (eradication therapy and prevention of rebleeding); treatment and prevention of gastrointestinal disorders caused by anti-inflammatory drugs
This medication is used for the treatment and prevention of gastroesophageal reflux disease and erosive esophagitis. It is also helpful in alleviating symptoms of gastroesophageal reflux disease without esophagitis. Additionally, it is effective in treating and preventing recurrence of duodenal ulcers and peptic ulcers as part of a combination therapy with antibiotics for Helicobacter pylori eradication. It provides short-term relief of upper gastrointestinal symptoms (pain, discomfort, burning) related to non-steroidal anti-inflammatory drug use, and is used for the treatment and prevention of gastric ulcers. It is included in maintenance therapy for Zollinger-Ellison syndrome and to prevent rebleeding from gastric or duodenal ulcers. Overall, it helps improve symptoms and supports treatment in various gastrointestinal conditions.
This product should be swallowed with a liquid such as water and should not be chewed or crushed. 1. Adults 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent relapse in patients with esophagitis: 20mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. · Once symptoms have resolved, subsequent symptoms may be controlled by administering 20mg once daily. · In adults, 20mg may be administered once daily as needed. As-needed administration is not recommended for ongoing symptom control in patients at high risk of developing gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. 2) Concomitant antibiotic therapy for Helicobacter pylori eradication Administer this product 20mg in combination with amoxicillin 1g and clarithromycin 500mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. Clinical trials exceeding 4 weeks have not been conducted. 4) Patients requiring continued treatment with nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with use of nonsteroidal anti-inflammatory drugs: 20mg once daily. The treatment duration is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with use of nonsteroidal anti-inflammatory drugs: 20mg once daily 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should be continued while clinical symptoms are present. Clinical data indicate that most patients can be controlled with a dose of 80∼160mg per day. Doses exceeding 80mg per day should be divided into 2 doses. 6) Maintenance therapy after induction of prevention of rebleeding due to gastric or duodenal ulcers by intravenous injection Administer 40mg once daily for 4 weeks after induction of prevention of rebleeding due to gastric or duodenal ulcers by intravenous injection. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal failure. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this product should not exceed 20mg. 6. Elderly patients No dose adjustment is necessary.
Adolescents aged 12 years and older: Treatment of erosive reflux esophagitis: Administer 40mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. Adolescents aged 12 years and older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is necessary. Adolescents aged 12 years and older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent symptoms may be controlled by administering 20mg once daily. Children under 12 years of age: There is no experience with administration of this product to children under 12 years of age.
This medication should not be used in patients with known allergies to specific components or who have had hypersensitivity reactions. Also, patients taking certain antibiotics or antivirals, those with a history of myocardial infarction, or nursing mothers should avoid this medication. This medication may cause various adverse reactions, with common occurrences being headaches, abdominal pain, diarrhea, skin rash, and muscle pain. Rarely, serious blood abnormalities, liver function impairment, and severe allergic reactions have been reported, necessitating caution. Regular monitoring is needed during long-term use, especially since magnesium levels may drop. This medication reduces stomach acid and may increase the risk of infections due to increased bacterial growth in the gastrointestinal tract, so if diarrhea persists, consult a physician. Additionally, patients with osteoporosis should be cautious as the risk of fractures may increase. This medication interacts with many other drugs, so follow a doctor's instructions when co-administering. Some drugs are contraindicated for use together. Use with caution during pregnancy, and it is preferable not to use it while nursing. There are no specific antidotes in case of overdose, so supportive treatment for symptoms is necessary, and it should be kept out of reach of children. Be cautious with transferring medication to different containers, as it may not be good for maintaining quality.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reactions, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal bloating, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, Riel syndrome, acute generalized pustular psoriasis, eosinophilia, systemic drug reactions accompanied by symptoms, fractures, arthralgia, myalgia, muscle weakness, nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal bloating, allergic reactions, back pain, chest pain, retrosternal pain, facial swelling, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, goiter, irritable bowel syndrome, exacerbation of constipation, dyspepsia, dysphagia, gastrointestinal developmental disorders, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue swelling, ulcerative stomatitis, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatic polymyalgia, anorexia, apathy, increased appetite, confusion, exacerbation of depression, muscle hypertonicity, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremors, visual field defects, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyp, nodule, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric pyloric polyp, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, at room temperature between 1°C and 30°C. Storing it this way will maintain the effectiveness of the medication and ensure its safety.
Pink, round film-coated tablet
28 tablets/box [14 tablets/Alu-Alu×2], 28 tablets/box [7 tablets/Alu-Alu×4]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Korea Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.